Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%

PHASE3CompletedINTERVENTIONAL
Enrollment

1,075

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

November 30, 2008

Conditions
Acne Vulgaris
Interventions
DRUG

Adapalene lotion 0.1%

Adapalene, 0.1% will be applied topically to the face, once a day, for 12 weeks

DRUG

Adapalene Lotion Vehicle

Adapalene Lotion Vehicle will be applied topically to the face, once a day, for 12 weeks

Trial Locations (34)

11790

Derm Research Center of New York, Stony Brook

14609

Elizabeth Arthur, Rochester

23507

Virginia Clinical Research, Inc., Norfolk

28601

Unifour Medical Research Associates, Hickory

30904

Anne M. Loebl, Augusta

33144

International Dermatology Research, Inc., Miami

34711

Advanced Dermatology, Clermont

37072

Rivergate Dermatology, Goodlettsville

44118

Haber Dermatology & Cosmetic Research, South Euclid

46617

Sound Bend Clinic, South Bend

48060

Hamzavi Dermatology, Port Huron

60089

Scott Glazer, Buffalo Grove

63117

Central Dermatology, PC, St Louis

71913

Burke Pharmaceutical Research, Hot Springs

72205

Scott Dinehart, Little Rock

73104

OU Health Sciences Center-Dept. of Dermatology, Oklahoma City

77058

Center for Clinical Studies, Houston

78229

Progressive Clinical Research, San Antonio

78759

DermResearch, Inc., Austin

80210

Colorado Medical Research Center, Denver

80501

Longmont Clinic, Longmont

87106

Academic Dermatology, Albuquerque

90292

Dermatology and Laser Center, Marina del Rey

92123

Therapeutics Clinical Research, San Diego

94589

Solano Clinical Research, Vallejo

97223

Oregon Medical Center, PC, Portland

03756

Darmouth-Hitchcock Medical Center Section of Dermatology, Lebanon

T2S 3B3

The Dermatology Centre, Calgary

T5K 1X3

Stratica Medical, Edmonton

T3A2N1

Guildford Dermatology Specialists, Surrey

R3C 1R4

Dermadvance Research, Winnipeg

A1B 3E1

Nexus Clinical Research, St. John's

L3P 6L2

Lynderm Research, Inc., Markham

N2J 1C4

K. Papp Clinical Research, Inc., Waterloo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Galderma R&D

INDUSTRY